Arcelia Marlane Guerson Gil

Arcelia Guerson Gil practices at Digestive Disease Center - HOPD in Laguna Hills, California.

Arcelia Guerson Gil's NPI, 1770087108, was assigned on March 20, 2018. Arcelia Guerson Gil holds California license A196580.

Arcelia Guerson Gil's primary practice is Digestive Disease Center - HOPD, at 24411 Health Center Dr, Laguna Hills, CA 92653.

Arcelia Guerson Gil's primary practice is Digestive Disease Center - HOPD in Laguna Hills, California. Arcelia Guerson Gil is also affiliated with Sanford Broadway Medical Center. The medical group on file is Optum - Downtown Los Angeles. Dmand AI also links Arcelia Guerson Gil to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Arcelia Guerson Gil practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Arcelia Guerson Gil's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Arcelia Guerson Gil is licensed in California.

CMS data shows 14 Medicare services from Arcelia Guerson Gil across 1 procedure code in 2024, all of them office visits, for 22 Medicare patients. Medicare paid $2,001 for them. Every service was in an office.

CMS counts 22 Medicare patients who saw Arcelia Guerson Gil in 2024. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Arcelia Guerson Gil's median patient age at 67, with 71% women.

In 2024, Arcelia Guerson Gil wrote 151 Medicare Part D claims for 115 patients. 72% of them were for generic drugs. CMS names the drug for 90 of them, across 3 drugs with 11 or more claims each, at $6,761 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Arcelia Guerson Gil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 49 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Arcelia Guerson Gil, more than 63% of the clinicians it reports for that procedure.

CMS Open Payments shows 49 general payments to Arcelia Guerson Gil from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 87% of the total. Abbvie Inc. paid the most, $794.